Status:
COMPLETED
Gabapentin Premedication for ACL Reconstruction: RCT
Lead Sponsor:
Children's Healthcare of Atlanta
Conditions:
Anterior Cruciate Ligament (ACL) Reconstruction
Eligibility:
All Genders
12-18 years
Brief Summary
This double blind randomized control trial will enroll 100 participants ages 12-18 years, undergoing ACL repair. Participants receive gabapentin or placebo preoperatively. Outcome measurements of self...
Detailed Description
Anterior Cruciate Ligament (ACL) injury and surgical repair occurs in 200,000 active adolescent and young adult patients each year. ACL repair is associated with significant postoperative pain. Curren...
Eligibility Criteria
Inclusion
- ASA classification 1 or 2
- Scheduled for elective ACL surgery in pediatric outpatient setting
Exclusion
- BMI greater than 40
- ASA classification greater than 2
- Recurrent ACL reconstruction
- Allograft ACL reconstruction
- History of renal insufficiency
- History of chronic pain
- Allergy to Gabapentin
Key Trial Info
Start Date :
October 9 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 23 2018
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT03417479
Start Date
October 9 2015
End Date
October 23 2018
Last Update
December 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30043